Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedernews.google.com
acalabrutinib - Google News
Get the latest updates from acalabrutinib - Google News directly as they happen.
Follow now < 10 followers
Latest posts
Last updated 7 months ago
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma - The ASCO Post
7 months ago
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma The ASCO Post
Low Cardiac Risk Among Patients with CLL Treated with Acalabrutinib - DocWire News
7 months ago
Low Cardiac Risk Among Patients with CLL Treated with Acalabrutinib DocWire News
Jain and Participants Consider BTK Inhibitor Resistance in CLL - Targeted Oncology
7 months ago
Jain and Participants Consider BTK Inhibitor Resistance in CLL Targeted Oncology
New Approvals for Acalabrutinib in Mantle Cell Lymphoma - American Association for Cancer Research (AACR)
7 months ago
New Approvals for Acalabrutinib in Mantle Cell Lymphoma American Association for Cancer...
Acalabrutinib Plus Venetoclax/Obinutuzumab Demonstrates Efficacy, Safety in Mantle Cell Lymphoma - OncLive
8 months ago
Acalabrutinib Plus Venetoclax/Obinutuzumab Demonstrates Efficacy, Safety in Mantle Cell Lymphoma OncLive
“All-Tablet” Treatment Shows Promise for Common Form of Leukemia - Technology Networks
8 months ago
“All-Tablet” Treatment Shows Promise for Common Form of Leukemia Technology Networks
“All-Tablet” Treatment Shows Promise for Common Form of Leukemia - Technology Networks
8 months ago
“All-Tablet” Treatment Shows Promise for Common Form of Leukemia Technology Networks
AVO Therapy Found Effective and Well Tolerated in High-Risk CLL - Oncology Nurse Advisor
8 months ago
AVO Therapy Found Effective and Well Tolerated in High-Risk CLL Oncology Nurse...
Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia - nejm.org
8 months ago
Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia nejm.org
Selection of Next-Gen BTK in CLL Limited By Lack of Direct Comparison - Targeted Oncology
8 months ago
Selection of Next-Gen BTK in CLL Limited By Lack of Direct Comparison...
OncLive’s FDA Approval Report: The Regulatory Rundown for January 2025 - OncLive
8 months ago
OncLive’s FDA Approval Report: The Regulatory Rundown for January 2025 OncLive
Oncology Drugs Approved by the FDA in January 2025 - www.oncnursingnews.com/
8 months ago
Oncology Drugs Approved by the FDA in January 2025 www.oncnursingnews.com/